BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 21335570)

  • 1. Dementia in Parkinson's disease: a 20-year neuropsychological study (Sydney Multicentre Study).
    Reid WG; Hely MA; Morris JG; Loy C; Halliday GM
    J Neurol Neurosurg Psychiatry; 2011 Sep; 82(9):1033-7. PubMed ID: 21335570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evolution of dementia in idiopathic Parkinson's disease: neuropsychological and clinical evidence in support of subtypes.
    Reid WG
    Int Psychogeriatr; 1992; 4 Suppl 2():147-60. PubMed ID: 1288660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mild cognitive impairment in Parkinson's disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort.
    Hobson P; Meara J
    Int J Geriatr Psychiatry; 2015 Oct; 30(10):1048-55. PubMed ID: 25676160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of dementia in Parkinson's disease; findings from a 5-year prospective study using the SCOPA-COG.
    Zhu K; van Hilten JJ; Marinus J
    Parkinsonism Relat Disord; 2014 Sep; 20(9):980-5. PubMed ID: 25024059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploratory analysis of neuropsychological and neuroanatomical correlates of progressive mild cognitive impairment in Parkinson's disease.
    Lee JE; Cho KH; Song SK; Kim HJ; Lee HS; Sohn YH; Lee PH
    J Neurol Neurosurg Psychiatry; 2014 Jan; 85(1):7-16. PubMed ID: 23828835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal changes in cognition in Parkinson's disease with and without dementia.
    Johnson DK; Galvin JE
    Dement Geriatr Cogn Disord; 2011; 31(2):98-108. PubMed ID: 21242691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural history of treated Parkinson's disease in an incident, community based cohort.
    Evans JR; Mason SL; Williams-Gray CH; Foltynie T; Brayne C; Robbins TW; Barker RA
    J Neurol Neurosurg Psychiatry; 2011 Oct; 82(10):1112-8. PubMed ID: 21593513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mild cognitive impairment in Parkinson's disease: Diagnosis and progression to dementia.
    Galtier I; Nieto A; Lorenzo JN; Barroso J
    J Clin Exp Neuropsychol; 2016; 38(1):40-50. PubMed ID: 26602176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease.
    Giladi N; Treves TA; Paleacu D; Shabtai H; Orlov Y; Kandinov B; Simon ES; Korczyn AD
    J Neural Transm (Vienna); 2000; 107(1):59-71. PubMed ID: 10809404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal assessment of the pattern of cognitive decline in non-demented patients with advanced Parkinson's disease.
    Gasca-Salas C; Estanga A; Clavero P; Aguilar-Palacio I; González-Redondo R; Obeso JA; Rodríguez-Oroz MC
    J Parkinsons Dis; 2014; 4(4):677-86. PubMed ID: 25208730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients.
    Merola A; Zibetti M; Angrisano S; Rizzi L; Ricchi V; Artusi CA; Lanotte M; Rizzone MG; Lopiano L
    Brain; 2011 Jul; 134(Pt 7):2074-84. PubMed ID: 21666262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of age of onset of PD on risk of dementia.
    Aarsland D; Kvaløy JT; Andersen K; Larsen JP; Tang MX; Lolk A; Kragh-Sørensen P; Marder K
    J Neurol; 2007 Jan; 254(1):38-45. PubMed ID: 17508138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinson's disease and dementia: a longitudinal study (DEMPARK).
    Balzer-Geldsetzer M; Costa AS; Kronenbürger M; Schulz JB; Röske S; Spottke A; Wüllner U; Klockgether T; Storch A; Schneider C; Riedel O; Wittchen HU; Seifried C; Hilker R; Schmidt N; Witt K; Deuschl G; Mollenhauer B; Trenkwalder C; Liepelt-Scarfone I; Gräber-Sultan S; Berg D; Gasser T; Kalbe E; Bodden M; Oertel WH; Dodel R
    Neuroepidemiology; 2011; 37(3-4):168-76. PubMed ID: 22067139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of depression and Parkinson's disease on cognitive functioning.
    Norman S; Tröster AI; Fields JA; Brooks R
    J Neuropsychiatry Clin Neurosci; 2002; 14(1):31-6. PubMed ID: 11884652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychological characteristics of preclinical dementia in Parkinson's disease.
    Jacobs DM; Marder K; Côté LJ; Sano M; Stern Y; Mayeux R
    Neurology; 1995 Sep; 45(9):1691-6. PubMed ID: 7675228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia.
    Stoffers D; Bosboom JL; Deijen JB; Wolters EC; Berendse HW; Stam CJ
    Brain; 2007 Jul; 130(Pt 7):1847-60. PubMed ID: 17412733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive characteristics associated with mild cognitive impairment in Parkinson's disease.
    McKinlay A; Grace RC; Dalrymple-Alford JC; Roger D
    Dement Geriatr Cogn Disord; 2009; 28(2):121-9. PubMed ID: 19690414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age of disease onset influences cognition in Parkinson's disease.
    Katzen HL; Levin BE; Llabre ML
    J Int Neuropsychol Soc; 1998 May; 4(3):285-90. PubMed ID: 9623003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal EEG changes correlate with cognitive measure deterioration in Parkinson's disease.
    Caviness JN; Hentz JG; Belden CM; Shill HA; Driver-Dunckley ED; Sabbagh MN; Powell JJ; Adler CH
    J Parkinsons Dis; 2015; 5(1):117-24. PubMed ID: 25420672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A registry-based, case-control investigation of Parkinson's disease with and without cognitive impairment.
    Papapetropoulos S; Ellul J; Polychronopoulos P; Chroni E
    Eur J Neurol; 2004 May; 11(5):347-51. PubMed ID: 15142230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.